menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Developments in DMD Treatment: The First Nonsteroidal Drug Approval

ReachMD Healthcare Image
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
  • Overview

    Explore the data that led to the FDA approval of givinostat, the first nonsteroidal treatment option for patients with duchenne muscular dystrophy, with this brief recap.

Facebook Comments

Recommended
Details
Comments
  • Overview

    Explore the data that led to the FDA approval of givinostat, the first nonsteroidal treatment option for patients with duchenne muscular dystrophy, with this brief recap.

Facebook Comments

Schedule28 May 2024